Outcome measures in ANCA-associated vasculitis.

Outcome measures in ANCA-associated vasculitis.

The outcome in patients with antineutrophil cytoplasm antibody (ANCA)-associated vasculitis has considerably improved with the use of potent immunosuppression. In the most severe cases, mortality remains an important risk despite aggressive intervention. However, for most patients who survive, quali...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Suppiah, R, Robson, J, Luqmani, R
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2010

Ижил төстэй зүйлс

Cardiovascular outcomes in ANCA associated vasculitis
-н: Mukhtyar, C, зэрэг
Хэвлэсэн: (2008)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
-н: Suppiah, R, зэрэг
Хэвлэсэн: (2011)

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.
-н: Merkel, P, зэрэг
Хэвлэсэн: (2011)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials
-н: Suppiah, R, зэрэг
Хэвлэсэн: (2011)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
-н: Suppiah, R, зэрэг
Хэвлэсэн: (2011)

Damage assessment in ANCA-associated vasculitis.
-н: Bhamra, K, зэрэг
Хэвлэсэн: (2012)

Maintenance of clinical remission in ANCA-associated vasculitis.
-н: Luqmani, R
Хэвлэсэн: (2013)

Opinion: Maintenance of clinical remission in ANCA-associated vasculitis
-н: Luqmani, R
Хэвлэсэн: (2013)

Cutaneous manifestations of ANCA-associated vasculitis
-н: Chiesafuxench, Z, зэрэг
Хэвлэсэн: (2016)

Diagnosis and management of ANCA associated vasculitis.
-н: Berden, A, зэрэг
Хэвлэсэн: (2012)

Comparison of disease activity measures for ANCA-associated vasculitis.
-н: Merkel, P, зэрэг
Хэвлэсэн: (2004)

ANCA-associated vasculitis: Where can we go from here?
-н: Luqmani, R
Хэвлэсэн: (2010)

TREATMENT-RELATED DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
-н: Robson, J, зэрэг
Хэвлэсэн: (2013)

Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire
-н: Robson, J, зэрэг
Хэвлэсэн: (2018)

Explaining fatigue in ANCA-associated vasculitis.
-н: Basu, N, зэрэг
Хэвлэсэн: (2013)

Explaining fatigue in ANCA-associated vasculitis
-н: Basu, N, зэрэг
Хэвлэсэн: (2013)

Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients.
-н: Arnold, D, зэрэг
Хэвлэсэн: (2010)

Predictors of renal involvement in ANCA associated vasculitis
-н: Kronbichler, A, зэрэг
Хэвлэсэн: (2018)

THE DEMOGRAPHY OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
-н: Yew, S, зэрэг
Хэвлэсэн: (2012)

DEVELOPMENT OF DIAGNOSTIC CRITERIA FOR PRIMARY ANCA-ASSOCIATED SYSTEMIC VASCULITIS (AASV)
-н: McLaren, J, зэрэг
Хэвлэсэн: (2003)

Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials.
-н: Robson, J, зэрэг
Хэвлэсэн: (2015)

Damage in the ANCA-associated vasculitides: Long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials
-н: Robson, J, зэрэг
Хэвлэсэн: (2015)

Markers for work disability in ANCA-associated vasculitis
-н: Basu, N, зэрэг
Хэвлэсэн: (2013)

Long-term survival of ANCA-associated vasculitis
-н: Flossmann, O, зэрэг
Хэвлэсэн: (2009)

Global ethnic and geographic idfferences in the clinical features of ANCA-associated vasculitis
-н: Pearce, F, зэрэг
Хэвлэсэн: (2016)

THE DISEASE CHARACTERISTICS OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
-н: Yew, S, зэрэг
Хэвлэсэн: (2012)

FACTORS ASSOCIATED WITH LONG-TERM DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF COHORTS FROM THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
-н: Robson, J, зэрэг
Хэвлэсэн: (2013)

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
-н: Jones, R, зэрэг
Хэвлэсэн: (2010)

Cutaneous manifestations of ANCA-associated vasculitis are common, varied, and associated with systemic disease
-н: Micheletti, R, зэрэг
Хэвлэсэн: (2017)

A disease-specific patient-reported outcome for ANCA associated vasculitis: scale structure and measurement properties of the AAV- PRO
-н: Robson, J, зэрэг
Хэвлэсэн: (2017)

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.
-н: Ntatsaki, E, зэрэг
Хэвлэсэн: (2014)

BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
-н: Lapraik, C, зэрэг
Хэвлэсэн: (2007)

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.
-н: Merkel, P, зэрэг
Хэвлэсэн: (2009)

The characterisation and determinants of quality of life in ANCA associated vasculitis.
-н: Basu, N, зэрэг
Хэвлэсэн: (2014)

The characterisation and determinants of quality of life in ANCA associated vasculitis
-н: Basu, N, зэрэг
Хэвлэсэн: (2014)

CONTEXTUALISING QUALITY OF LIFE IN ANCA ASSOCIATED VASCULITIS (AAV)
-н: Basu, N, зэрэг
Хэвлэсэн: (2012)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
-н: Robson, J, зэрэг
Хэвлэсэн: (2018)

Association between age at diagnosis and clinical presentation and outcomes of anca-associated vasculitis. analysis from the dcvas study
-н: Monti, S, зэрэг
Хэвлэсэн: (2018)

Updates in ANCA-associated vasculitis
-н: Carolyn Ross, зэрэг
Хэвлэсэн: (2022-07-01)

Epidemiology of ANCA associated vasculitis
-н: Wenche Koldingsnes, зэрэг
Хэвлэсэн: (2008-01-01)